Awareness of CBD Grows in Europe

November 22, 2019 16:00:28

Cannabidiol (CBD) is probably one of the most popular topics in the West at the moment. The hemp extract has garnered intense interest, especially in Europe and the U.S., with more people aware of the cannabinoid and its perceived medical benefits. Said to have potent and versatile medicinal properties, CBD has been found effective against a wide variety of medical conditions ranging from high blood pressure and anxiety to chronic pain and even cancer.

But as is expected of a sector that has seen massive growth over such a short period, there has been limited research and public education on the product. A recent survey of EU countries uncovered interesting aspects of…


About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published:

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.